White Matter Hyperintensities and Blood Pressure Lowering in Acute Intracerebral Hemorrhage: A Secondary Analysis of the ATACH-2 Trial.
Morotti AndreaAshkan ShoamaneshJamary Oliveira-FilhoFrieder SchlunkJavier M RomeroMichael JesselAlison AyresAnastasia VashkevichKristin SchwabChristy CassarlyRenee' Hebert MartinSteven M GreenbergAdnan I QureshiJonathan RosandJoshua N Goldsteinnull nullPublished in: Neurocritical care (2021)
The majority of acute ICH patients have moderate-severe WMH, but advanced small vessel disease burden marked by WMH does not influence ICH-related outcomes or response to intensive BP reduction.
Keyphrases
- liver failure
- blood pressure
- end stage renal disease
- white matter
- drug induced
- respiratory failure
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- clinical trial
- brain injury
- high intensity
- multiple sclerosis
- type diabetes
- adipose tissue
- phase ii
- patient reported
- open label
- blood glucose